Wong Kin Sang – Country Manager, Lundbeck Malaysia
Wong Kin Sang, country manager of Lundbeck Malaysia, walks us through the mental health issues’ perception in Malaysia and the important work Lundbeck has done to bring more awareness to…
Institut Jantung Negara (IJN) was established in 1992, as a cardiovascular and thoracic center. It has always tried to keep abreast with current advances and benchmarked with internationally acclaimed, established, advanced centers.
It has kept itself of international standards in quality in healthcare, presently accredited Joint Commission International JCI, Malaysian Society for Quality in Healthcare MSQH 3rd edition 2008 and ISO 9001:2008.
In our attempts to keep abreast with advances in cardiovascular and thoracic medicine, some of the recent procedures, surgeries, services, program are illustrated below:
Services:
Catheter-based Mitral Valve Repair with the MITRACLIP
Mitral regurgitation (MR) is a condition whereby the mitral valve leaks. As a result, a significant volume of blood is pushed backward into the left atrium. Left unattended, mitral regurgitation can lead to progressive enlargement of the heart and will lead to heart failure. Common causes for these leakages are usually either functional or degenerative. Conventional treatment of severe MR will be surgery, in the form of either mitral valve repair or replacement. However, this will require an open heart surgery. On occasions, the risk of surgery is high especially when there is coexisting medical conditions or advanced age.
Wong Kin Sang, country manager of Lundbeck Malaysia, walks us through the mental health issues’ perception in Malaysia and the important work Lundbeck has done to bring more awareness to…
Dr Hyzan Mohd Yusof, CEO at OSA Technology, tells the story of how he founded the company to address Malaysia’s unmet needs in medical devices as well as his vision…
How Malaysia is setting itself up to provide biosimilars across the Islamic world as well as Asia. Inno Bio Ventures, a Malaysian state-owned company originally set up to create…
Dr Ramli Zainal, the director at National Pharmaceutical Regulatory Agency (NPRA), expresses the continuous work of NPRA to build a strong regulatory ecosystem in Malaysia and the important role that…
Tan Sri Rahman Mamat, chairman of Inno Bio Ventures, provides his vision for biosimilars’ potential in Malaysia, and the progress the company has made in laying the foundations to make…
George Kazzi, general manager of Baxter Malaysia, highlights the main areas of development for his affiliate, including the introduction of more renal dialysis innovation as well as increasing awareness and…
Dr Dhesi Baha Raja, consultant in digital technologies at the Malaysian Ministry of Health, introduces the government’s plan to enter digital health through electronic medical records (EMR) and shares his…
Kshitij Panse, director of Servier Malaysia discusses the company’s planned move into oncology, as well as their strategies to provide an all-round improved patient experience, through education, screening, and e-health.…
Datuk Dr Noor Hisham Abdullah, director general of health at the Ministry of Health of Malaysia unveils the government’s plan to bring healthcare back to the community, and create a…
Dr. Azrul Mohd Khalib, chief executive at the Galen Centre for Health and Social Policy, gives an insight on the current important issues the Malaysian healthcare ecosystem is facing and…
Malaysia’s multi-ethnic population, disease burden, medical infrastructure and research speed, combined with its population’s proficiency in English, make the Southeast Asian nation a potentially excellent regional clinical trials destination. …
Shahnas Oli Mohamed, the managing director of Natural Wellness Holdings Sdn Bhd, expresses the important work that Natural Wellness has done to provide natural healthcare products to Malaysian patients, including…
See our Cookie Privacy Policy Here